Post-Marketing Experience With the Levalap™ 1.0: Improved Abdominal Access WHEN Using the Veress Needle During Laparoscopic Surgery.

Autor: Deffieux, X, Hackenthal, A, Benifla, JL, Juhasz-Böess, I, Breitbach, M, Buchweitz, O, Habib, N, Hald, K, Haj Hamoud, B, Huchon, C, Lysdal, V, Nigelis, M, Rudnicki, M, Solomayer, E, Taran, FA, Michelsen-Wahl, H, Azziz, R, Bagnardi, V

Publikováno v: Journal of Minimally Invasive Gynecology; 2024 Supplement, Vol. 31 Issue 11, pS33-S34, 2p

Clinical characteristics indicating adenomyosis at the time of hysterectomy: a retrospective study in 291 patients.

Autor: Taran FA, Wallwiener M, Kabashi D, Rothmund R, Rall K, Kraemer B, Brucker SY

Publikováno v: Archives of Gynecology & Obstetrics; Jun2012, Vol. 285 Issue 6, p1571-1576, 6p

Stellenwert der FDG-PET/MRT und Sentinel Node (SLN) SPECT/CT beim Lymphknotenstaging des frühen Zervix-und Endometriumkarzinoms

Autor: Weissinger, M, Taran, FA, Brucker, S, Reimold, M, Gatidis, S, Pfannenberg, C, Nikolaou, K, la Fougère, C, Dittmann, H

Publikováno v: Nuklearmedizin. Nuclear medicine; March 2019, Vol. 58 Issue: 2

Can Ki-67 serve as a suitable marker to indicate the necessity of staging diagnostics in cases of low-risk breast cancer?

Autor: Jung L; Department of Obstetrics and Gynecology at the Medical Center, University of Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany. lisa.jung@uniklinik-freiburg.de., Huwer SI; Department of Obstetrics and Gynecology at the Medical Center, University of Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Jungmann P; Department of Obstetrics and Gynecology at the Medical Center, University of Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Medl M; Department of Obstetrics and Gynecology at the Medical Center, University of Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Taran FA; Department of Obstetrics and Gynecology at the Medical Center, University of Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Neubauer J; Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany., Wilpert C; Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany., Juhasz-Böss I; Department of Obstetrics and Gynecology at the Medical Center, University of Freiburg, Hugstetterstr. 55, 79106, Freiburg, Germany., Müller C; Department of Obstetrics & Gynecology, Saarland University Medical Center, University of Saarland, Homburg, Germany.; Department of Anesthesiology, Outcomes Research Consortium, Cleveland Clinic, Cleveland, OH, USA.

Publikováno v: Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.

The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.

Autor: Ziegler P; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen Nürnberg, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, 91054, Germany., Hartkopf AD; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Wallwiener M; Department of Gynecology, Halle University Hospital, Halle, Germany., Häberle L; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen Nürnberg, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, 91054, Germany.; Biostatistics Unit, Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Erlangen, Germany., Kolberg HC; Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany., Hadji P; Frankfurt Center for Bone Health, Frankfurt Am Main, Germany., Tesch H; Oncology Practice, Bethanien Hospital, Frankfurt Am Main, Germany., Ettl J; Department of Obstetrics and Gynecology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.; Cancer Center Kempten/ Allgäu (CCKA), Klinikum Kempten, Kempten, Germany., Lüftner D; Immanuel Hospital Märkische Schweiz & Immanuel Campus Rüdersdorf, Medical University of Brandenburg Theodor-Fontane, Rüdersdorf Bei Berlin, Germany., Müller V; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany., Michel LL; National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg University Hospital, Heidelberg, Germany., Belleville E; ClinSol GmbH & Co KG, Würzburg, Germany., Wimberger P; National Center for Tumor Diseases Dresden and Department of Gynecology and Obstetrics, University Hospital Dresden, TU Dresden, Dresden, Germany., Hielscher C; g.SUND Gynäkologie-Onkologisches Zentrum, Stralsund, Germany., Huebner H; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen Nürnberg, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, 91054, Germany., Uhrig S; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen Nürnberg, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, 91054, Germany., Wurmthaler LA; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen Nürnberg, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, 91054, Germany., Hack CC; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen Nürnberg, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, 91054, Germany., Mundhenke C; Department of Gynecology and Obstetrics, Klinik Hohe Warte, Bayreuth, Germany., Kurbacher C; Department of Gynecology I (Gynecologic Oncology), Gynecologic Center Bonn-Friedensplatz, Bonn, Germany., Fasching PA; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen Nürnberg, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, 91054, Germany. peter.fasching@uk-erlangen.de., Wuerstlein R; Department of Gynecology and Obstetrics, Breast Center and CCC Munich, University Hospital LMU Munich, Munich, Germany., Untch M; Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany., Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Taran FA; Department of Obstetrics and Gynecology, University Medical Center Freiburg, Freiburg, Germany., Lux MP; Department of Gynecology and Obstetrics, Frauenklinik St. LouiseSt. Josefs-KrankenhausVincenz Kliniken Salzkotten + Paderborn, Paderborn, Germany., Wallwiener D; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Brucker SY; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Fehm TN; Department of Gynecology and Obstetrics, Düsseldorf University Hospital, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, Düsseldorf, Germany., Schneeweiss A; National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg University Hospital, Heidelberg, Germany., Goossens C; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen Nürnberg, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, 91054, Germany.

Publikováno v: BMC cancer [BMC Cancer] 2024 Oct 16; Vol. 24 (1), pp. 1284. Date of Electronic Publication: 2024 Oct 16.